Global Phage Therapy Market 2024-2028
The phage therapy market is forecasted to grow by USD 51 mn during 2023-2028, accelerating at a CAGR of 17.41% during the forecast period. The report on the phage therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by benefits of phage therapy over antibiotics, increasing application of phage therapy for animal health, and increasing application of phage therapy for human health.
Technavio's phage therapy market is segmented as below:
By Product
- Escherichia coli
- Staphylococcus aureus
- Salmonella
- Others
By Application
- Animal health
- Food industry
- Others
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
This study identifies the increasing investments in phage therapy as one of the prime reasons driving the phage therapy market growth during the next few years. Also, increasing clinical trials for phage therapy and increasing number of partnerships among vendors will lead to sizable demand in the market.
The report on the phage therapy market covers the following areas:
- Phage therapy market sizing
- Phage therapy market forecast
- Phage therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading phage therapy market vendors that include Adaptive Phage Therapeutics, APS Biocontrol Ltd., Armata Pharmaceuticals Inc., Astellas Pharma Inc., BiomX Inc., CJ CheilJedang Corp., Cytophage Technologies Inc., Eliava Biopreparation LLC, Intralytix Inc., iNtRON Biotechnology Inc., JSC NPO Microgen, Locus Biosciences Inc., Micreos, Micromir, Nexabiome, Proteon Pharmaceuticals S.A., Taconic Biosciences Inc., TechnoPhage, ZeptoMetrix LLC, and Vitalis Wellness LLP. Also, the phage therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.